Department of Urology, Santa Chiara Regional Hospital, Trento, Italy.
Department of Urology, University of Naples, Naples, Italy.
Eur Urol. 2016 Feb;69(2):276-83. doi: 10.1016/j.eururo.2015.05.010. Epub 2015 May 20.
The evolution of resistant pathogens is a worldwide health crisis and adherence to European Association of Urology (EAU) guidelines on antibiotic prophylaxis may be an important way to improve antibiotic stewardship and reduce patient harm and costs.
To evaluate the prevalence of antibiotic-resistant bacterial strains and health care costs during a period of adherence to EAU guidelines in a tertiary referral urologic institution.
DESIGN, SETTING, AND PARTICIPANTS: A protocol for adherence to EAU guidelines for antibiotic prophylaxis for all urologic procedures was introduced in January 2011. Data for 3529 urologic procedures performed between January 2011 and December 2013 after protocol introduction were compared with data for 2619 procedures performed between January 2008 and December 2010 before protocol implementation. The prevalence of bacterial resistance and health care costs were compared between the two periods.
The outcome measures were the proportion of resistant uropathogens and costs related to antibiotic consumption and symptomatic postoperative infection. We used χ2 and Fisher's exact tests to test the significance of differences.
The proportion of patients with symptomatic postoperative infection did not differ (180/3529 [5.1%] vs. 117/2619 [4.5%]; p=0.27). A total of 342 isolates from all patients with symptomatic postoperative infections were analysed. The rate of resistance of Escherichia coli to piperacillin/tazobactam (9.1% vs. 5.4%; p=0.03), gentamicin (18.3% vs. 11.2%; p=0.02), and ciprofloxacin (32.3% vs. 19.1%; p=0.03) decreased significantly after protocol introduction. The defined daily dose (DDD) use of ciprofloxacin fell from 4.2 to 0.2 DDD per 100 patient-days after implementation (p<0.001). Antibiotic drug costs (€76,980 vs. €36,700) and costs related to postoperative infections (€45,870 vs. €29,560) decreased following introduction of the protocol (p<0.001).
Adherence to EAU guidelines on antibiotic prophylaxis reduced antibiotic usage without increasing post-operative infection rate and lowered the prevalence of resistant uropathogens.
We analysed the impact of adherence to European Association of Urology guidelines on antibiotic prophylaxis for all surgical urologic procedures on the prevalence of infections and resistant bacterial strains and on costs. We found that adherence to the guidelines reduced the rate of bacterial resistance, in particular against piperacillin/tazobactam, gentamicin, and ciprofloxacin, and reduced costs without increasing the risk of postoperative infection after urologic procedures. We recommend adherence to the guidelines as an important part of antibiotic stewardship programmes.
耐药病原体的进化是全球范围内的健康危机,遵循欧洲泌尿外科学会(EAU)的抗生素预防指南可能是改善抗生素管理、减少患者伤害和降低成本的重要途径。
评估在一家三级转诊泌尿科机构遵循 EAU 指南进行抗生素预防期间,耐药细菌菌株的流行情况和医疗保健成本。
设计、设置和参与者:2011 年 1 月引入了一项关于所有泌尿科手术抗生素预防的 EAU 指南遵循方案。比较了 2011 年 1 月至 2013 年 12 月方案实施后进行的 3529 例泌尿科手术的数据,以及 2008 年 1 月至 2010 年 12 月方案实施前进行的 2619 例手术的数据。比较了两个时期的细菌耐药性和医疗保健成本。
观察指标为尿路感染病原体的耐药比例以及与抗生素消耗和术后症状性感染相关的成本。我们使用 χ2 和 Fisher's 精确检验来检验差异的显著性。
术后症状性感染患者的比例无差异(3529 例患者中有 180 例[5.1%] vs. 2619 例患者中有 117 例[4.5%];p=0.27)。对所有术后症状性感染患者的 342 株分离株进行了分析。大肠杆菌对哌拉西林/他唑巴坦(9.1% vs. 5.4%;p=0.03)、庆大霉素(18.3% vs. 11.2%;p=0.02)和环丙沙星(32.3% vs. 19.1%;p=0.03)的耐药率显著降低。环丙沙星的限定日剂量(DDD)使用量从实施前的 4.2 下降至 0.2 DDD/100 患者天(p<0.001)。抗生素药物费用(€76980 与 €36700)和术后感染相关费用(€45870 与 €29560)均降低(p<0.001)。
遵循 EAU 抗生素预防指南可减少抗生素使用量,而不会增加术后感染率,并降低尿路感染病原体的耐药率。
我们分析了遵循 EAU 所有泌尿科手术抗生素预防指南对感染和耐药细菌菌株的流行情况以及成本的影响。我们发现,遵循指南降低了细菌耐药率,特别是对哌拉西林/他唑巴坦、庆大霉素和环丙沙星的耐药率,并降低了成本,而不会增加泌尿科手术后的术后感染风险。我们建议将遵循指南作为抗生素管理计划的重要组成部分。